A phase I study in healthy males to determine the tolerability and safety of transdermally delivered oxycodone in combination with the novel penetration enhancer tocopheryl phosphate mix (TPM).
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Oxycodone (Primary) ; Oxycodone (Primary)
- Indications Pain
- Focus Adverse reactions
- 03 Sep 2013 Top-line results will be presented at the PAINWeek 2013 conference, according to a Phosphagenics media release.
- 01 Oct 2009 New trial record